These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 29440768)

  • 21. Deterministic Tractography of the Nigrostriatal-Nigropallidal Pathway in Parkinson's Disease.
    Tan WQ; Yeoh CS; Rumpel H; Nadkarni N; Lye WK; Tan EK; Chan LL
    Sci Rep; 2015 Dec; 5():17283. PubMed ID: 26619969
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Parkinson's disease: diffusion kurtosis imaging and the correlation with clinical manifestations].
    Sun YQ; Zhang Q; Jiang Z; Zhang CY; Zhang JW; Chen H; Shen JK
    Zhonghua Yi Xue Za Zhi; 2017 Dec; 97(45):3534-3537. PubMed ID: 29275590
    [No Abstract]   [Full Text] [Related]  

  • 23. Substantia Nigra Neuromelanin as an Imaging Biomarker of Disease Progression in Parkinson's Disease.
    Fabbri M; Reimão S; Carvalho M; Nunes RG; Abreu D; Guedes LC; Bouça R; Lobo PP; Godinho C; Coelho M; Gonçalves NC; Rosa MM; Antonini A; Ferreira JJ
    J Parkinsons Dis; 2017; 7(3):491-501. PubMed ID: 28671143
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Role of the combination of FA and T2* parameters as a new diagnostic method in therapeutic evaluation of parkinson's disease.
    Fang Y; Zheng T; Liu L; Gao D; Shi Q; Dong Y; Du D
    J Magn Reson Imaging; 2018 Jul; 48(1):84-93. PubMed ID: 29148118
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of Age on Substantia Nigra Hyper-echogenicity in Parkinson's Disease Patients and Healthy Controls.
    Toomsoo T; Liepelt-Scarfone I; Berg D; Kerner R; Pool AH; Kadastik-Eerme L; Rubanovits I; Asser T; Taba P
    Ultrasound Med Biol; 2019 Jan; 45(1):122-128. PubMed ID: 30482710
    [TBL] [Abstract][Full Text] [Related]  

  • 26. High-resolution diffusion tensor imaging in the substantia nigra of de novo Parkinson disease.
    Vaillancourt DE; Spraker MB; Prodoehl J; Abraham I; Corcos DM; Zhou XJ; Comella CL; Little DM
    Neurology; 2009 Apr; 72(16):1378-84. PubMed ID: 19129507
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Combination of Quantitative Susceptibility Mapping and Diffusion Kurtosis Imaging Provides Potential Biomarkers for Early-Stage Parkinson's Disease.
    Rong Y; Xu Z; Zhu Y; Zhang X; Lai L; Sun S; Gao M; Guo P; Zhang G; Geng Y; Ma X; Wu S; Yang L; Shen Z; Guan J
    ACS Chem Neurosci; 2022 Sep; 13(18):2699-2708. PubMed ID: 36047877
    [No Abstract]   [Full Text] [Related]  

  • 28. MRI diffusion in Parkinson's disease: using the technique's inherent directional information to study the olfactory bulb and substantia nigra.
    Skorpil M; Söderlund V; Sundin A; Svenningsson P
    J Parkinsons Dis; 2012; 2(2):171-80. PubMed ID: 23939442
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Diffusion tensor imaging in Parkinson's disease: Review and meta-analysis.
    Atkinson-Clement C; Pinto S; Eusebio A; Coulon O
    Neuroimage Clin; 2017; 16():98-110. PubMed ID: 28765809
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Substantia nigra fractional anisotropy is not a diagnostic biomarker of Parkinson's disease: A diagnostic performance study and meta-analysis.
    Hirata FCC; Sato JR; Vieira G; Lucato LT; Leite CC; Bor-Seng-Shu E; Pastorello BF; Otaduy MCG; Chaim KT; Campanholo KR; Novaes NP; Melo LM; Gonçalves MR; do Nascimento FBP; Teixeira MJ; Barbosa ER; Amaro E; Cardoso EF
    Eur Radiol; 2017 Jun; 27(6):2640-2648. PubMed ID: 27709279
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Short-echo-time magnitude image derived from quantitative susceptibility mapping could resemble neuromelanin-sensitive MRI image in substantia nigra.
    Liu XL; Yang LQ; Liu FT; Wu PY; Zhang Y; Zhuang H; Shi YH; Wang J; Geng DY; Li YX
    BMC Neurol; 2020 Jun; 20(1):262. PubMed ID: 32605601
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Does normal substantia nigra echogenicity make a difference in Parkinson's disease diagnosis? A real clinical practice follow-up study.
    Alonso-Canovas A; Lopez-Sendon Moreno JL; Buisan J; Sainz de la Maza S; Costa-Frossard L; Garcia-Ribas G; de Felipe-Mimbrera A; Matute-Lozano MC; Zarza Sanz B; Toledano Delgado R; Corral I; Masjuan J; Martinez-Castrillo JC
    J Neurol; 2018 Oct; 265(10):2363-2369. PubMed ID: 30116942
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Connectivity-based segmentation of the substantia nigra in human and its implications in Parkinson's disease.
    Menke RA; Jbabdi S; Miller KL; Matthews PM; Zarei M
    Neuroimage; 2010 Oct; 52(4):1175-80. PubMed ID: 20677376
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Neurite orientation dispersion and density imaging in the substantia nigra in idiopathic Parkinson disease.
    Kamagata K; Hatano T; Okuzumi A; Motoi Y; Abe O; Shimoji K; Kamiya K; Suzuki M; Hori M; Kumamaru KK; Hattori N; Aoki S
    Eur Radiol; 2016 Aug; 26(8):2567-77. PubMed ID: 26515546
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Fractional anisotropy in the substantia nigra in Parkinson's disease: a complex picture.
    Lenfeldt N; Larsson A; Nyberg L; Birgander R; Forsgren L
    Eur J Neurol; 2015 Oct; 22(10):1408-14. PubMed ID: 26118635
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Potential of Diffusion Tensor Imaging and Relaxometry for the Detection of Specific Pathological Alterations in Parkinson's Disease (PD).
    Esterhammer R; Seppi K; Reiter E; Pinter B; Mueller C; Kremser C; Zitzelsberger T; Nocker M; Scherfler C; Poewe W; Schocke M
    PLoS One; 2015; 10(12):e0145493. PubMed ID: 26713760
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Substantia Nigra Free Water Increases Longitudinally in Parkinson Disease.
    Guttuso T; Bergsland N; Hagemeier J; Lichter DG; Pasternak O; Zivadinov R
    AJNR Am J Neuroradiol; 2018 Mar; 39(3):479-484. PubMed ID: 29419398
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Transcranial Sonographic Alterations of Substantia Nigra and Third Ventricle in Parkinson's Disease with or without Dementia.
    Dong ZF; Wang CS; Zhang YC; Zhang Y; Sheng YJ; Hu H; Luo WF; Liu CF
    Chin Med J (Engl); 2017 Oct; 130(19):2291-2295. PubMed ID: 28937033
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Magnetic Resonance Imaging Biomarkers to Assess Substantia Nigra Damage in Idiopathic Rapid Eye Movement Sleep Behavior Disorder.
    Pyatigorskaya N; Gaurav R; Arnaldi D; Leu-Semenescu S; Yahia-Cherif L; Valabregue R; Vidailhet M; Arnulf I; Lehéricy S
    Sleep; 2017 Nov; 40(11):. PubMed ID: 28958075
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Altered cerebral perfusion and microstructure in advanced Parkinson's disease and their associations with clinical features.
    Liu Z; Zhang Y; Wang H; Xu D; You H; Zuo Z; Feng F
    Neurol Res; 2022 Jan; 44(1):47-56. PubMed ID: 34313185
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.